COSMO Pharmaceuticals SA (SW:COPN) — Stock Price

CHF61.20 CHF
▼ -0.81% today

COSMO Pharmaceuticals SA (SW:COPN) is currently trading at CHF61.20 CHF, down 0.81% today. Over the past 52 weeks, shares have ranged between CHF55.30 and CHF124.80. This page tracks COSMO Pharmaceuticals SA's live share price on the SW exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see COPN company net worth.

COSMO Pharmaceuticals SA (COPN) Stock Price Chart — Daily History & Trading Volume

The chart below tracks COSMO Pharmaceuticals SA's daily closing share price and trading volume on the SW exchange over the past year, giving a clear view of recent price momentum and liquidity.

COSMO Pharmaceuticals SA Income Statement — Revenue, Profit & Earnings by Year

COSMO Pharmaceuticals SA's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue CHF104.85 Million CHF266.79 Million CHF92.78 Million CHF102.09 Million CHF65.07 Million
Cost of Revenue CHF56.07 Million CHF19.86 Million CHF39.34 Million CHF18.76 Million CHF15.14 Million
Gross Profit CHF48.78 Million CHF246.92 Million CHF53.44 Million CHF83.33 Million CHF49.93 Million
Research & Development CHF32.30 Million CHF373.00K CHF18.81 Million CHF15.53 Million CHF11.36 Million
SG&A CHF63.00K CHF6.46 Million CHF5.30 Million CHF3.13 Million CHF2.47 Million
Total Operating Expenses CHF59.27 Million CHF98.04 Million CHF47.29 Million CHF55.27 Million CHF21.00 Million
Operating Income CHF-10.48 Million CHF148.88 Million CHF6.15 Million CHF28.06 Million CHF11.10 Million
EBITDA CHF2.36 Million CHF165.71 Million CHF19.70 Million CHF46.74 Million CHF17.81 Million
EBIT CHF-10.48 Million CHF153.42 Million CHF6.15 Million CHF33.63 Million CHF11.10 Million
Interest Expense CHF182.18K CHF114.31K CHF8.53 Million CHF9.31 Million CHF8.99 Million
Income Before Tax CHF-924.00K CHF153.37 Million CHF1.53 Million CHF24.47 Million CHF24.00 Million
Income Tax Expense CHF2.59 Million CHF20.18 Million CHF6.26 Million CHF6.97 Million CHF2.33 Million
Net Income CHF-3.63 Million CHF133.24 Million CHF-4.93 Million CHF17.23 Million CHF21.67 Million

COSMO Pharmaceuticals SA Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes COSMO Pharmaceuticals SA's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets CHF612.16 Million CHF646.77 Million CHF553.98 Million CHF759.59 Million CHF805.56 Million
Total Current Assets CHF183.14 Million CHF202.26 Million CHF102.23 Million CHF306.10 Million CHF275.85 Million
Cash & Equivalents — — — — —
Short-term Investments CHF66.84 Million CHF98.67 Million CHF0.00 CHF55.13 Million CHF23.65 Million
Net Receivables CHF25.60 Million CHF18.94 Million CHF28.45 Million CHF38.61 Million CHF24.45 Million
Inventory CHF10.42 Million CHF13.51 Million CHF14.20 Million CHF11.50 Million CHF13.12 Million
Property, Plant & Equipment CHF30.81 Million CHF29.09 Million CHF28.59 Million CHF30.28 Million CHF30.48 Million
Goodwill CHF23.99 Million CHF24.00 Million CHF24.00 Million CHF24.00 Million CHF24.00 Million
Total Liabilities CHF123.36 Million CHF141.68 Million CHF124.94 Million CHF295.80 Million CHF292.88 Million
Total Current Liabilities CHF25.50 Million CHF48.27 Million CHF25.71 Million CHF194.95 Million CHF21.24 Million
Long-term Debt CHF143.00K CHF282.00K CHF422.00K CHF559.00K CHF167.15 Million
Net Debt CHF-51.56 Million CHF-42.09 Million CHF-48.44 Million CHF-12.23 Million CHF-28.64 Million
Total Stockholder Equity CHF481.92 Million CHF498.33 Million CHF422.16 Million CHF456.93 Million CHF505.28 Million
Retained Earnings CHF315.86 Million CHF323.06 Million CHF296.52 Million CHF254.75 Million CHF293.31 Million

COSMO Pharmaceuticals SA Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how COSMO Pharmaceuticals SA generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow CHF-11.62 Million CHF162.41 Million CHF22.71 Million CHF33.23 Million CHF12.61 Million
Capital Expenditures CHF4.23 Million CHF5.65 Million CHF4.40 Million CHF7.31 Million CHF8.50 Million
Free Cash Flow CHF-15.85 Million CHF156.76 Million CHF18.31 Million CHF25.92 Million CHF4.11 Million
Investing Cash Flow CHF49.85 Million CHF-128.88 Million CHF42.30 Million CHF1.69 Million CHF24.86 Million
Financing Cash Flow CHF-24.61 Million CHF-40.22 Million CHF-211.27 Million CHF-46.13 Million CHF-27.25 Million
Dividends Paid CHF32.90 Million CHF32.09 Million CHF16.89 Million CHF15.61 Million CHF761.00K
Stock-Based Compensation CHF2.60 Million CHF2.07 Million CHF3.83 Million CHF2.08 Million CHF1.46 Million
Depreciation CHF12.84 Million CHF12.29 Million CHF14.26 Million CHF13.86 Million CHF7.37 Million
Change in Cash CHF11.18 Million CHF-5.98 Million CHF-135.55 Million CHF-12.73 Million CHF12.62 Million

COSMO Pharmaceuticals SA Earnings History — EPS Actual vs. Analyst Estimates

Track COSMO Pharmaceuticals SA's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Jul 20, 2026 — — —
Dec 31, 2025 -0.10 0.20 -150.25%
Sep 30, 2025 — 0.10 —
Jul 23, 2025 -0.13 1.30 -110.00%
May 23, 2025 — — —
Mar 21, 2025 3.43 3.86 -11.14%
Sep 30, 2024 — -0.28 —
Mar 23, 2023 0.00 0.89 -100.00%